Chemclin Diagnostics Co., Ltd. (SHA:688468)
China · Delayed Price · Currency is CNY 7.94
+0.08 (1.02%)
Feb 27, 2026, 3:00 PM CST
Chemclin Diagnostics Market Cap
Chemclin Diagnostics has a market cap or net worth of 3.13 billion as of February 27, 2026. Its market cap has increased by 18.15% in one year.
Market Cap
3.13B
Enterprise Value
2.51B
Revenue
353.32M
Ranking
n/a
PE Ratio
57.41
Stock Price
7.94
Market Cap Chart
Since April 9, 2021, Chemclin Diagnostics's market cap has decreased from 10.00B to 3.13B, a decrease of -68.67%. That is a compound annual growth rate of -21.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.13B | 8.17% |
| Dec 31, 2025 | 2.90B | 7.15% |
| Dec 31, 2024 | 2.70B | -37.53% |
| Dec 29, 2023 | 4.33B | 13.94% |
| Dec 30, 2022 | 3.80B | -47.15% |
| Dec 31, 2021 | 7.19B | -28.15% |
| Apr 9, 2021 | 10.00B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 8.03B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 7.10B |
| Cowealth Medical China | 6.76B |
| SMO ClinPlus CO.,LTD. | 5.37B |
| Thalys Medical Technology Group | 4.56B |
| Berry Genomics Co.,Ltd | 4.42B |
| Shanghai Labway Clinical Laboratory | 4.36B |